Water Treatment System Market to Reach USD 73.06 Billion by 2032, Owing to Rising Water Scarcity and Stringent Quality Standards

Austin, June 20, 2025 (GLOBE NEWSWIRE) — The Water Treatment System Market size was valued at USD 41.38 billion in 2024 and is expected to reach USD 73.06 billion by 2032, growing at a CAGR of 7.43% over the forecast period of 2025 2032. Rising concerns regarding water pollution and the need for safe drinking and industrial water are expected to drive the growth of the global water treatment system market. Push in Environmental Regulations and Sustainable Development has Encouraged Governments and Private entities to invest in advanced purification technologies at a rapid pace. This change makes it feasible for the residential, commercial, and industrial sectors to rely on advanced water treatment solutions for the improved quality of water and to save it as a resource.
The U.S. Water Treatment System Market size was valued at USD 6.44 billion in 2024 and is expected to reach USD 12.07 billion by 2032, growing at a CAGR of 8.24% over the forecast period of 2025 2032.
Download PDF Sample of Water Treatment System Market @ https://www.snsinsider.com/sample-request/7394
Key Players: 3M
Honeywell International Inc.
DuPont
Panasonic
Pentair plc
BWT Aktiengesellschaft
Culligan
Watts Water Technologies Inc.
Aquasana, Inc.
Calgon Carbon Corp.
Water Treatment System Market Report Scope: Report Attributes Details Market Size in 2024 USD 41.38 Billion Market Size by 2032 USD 73.06 Billion CAGR CAGR of 7.43% From 2025 to 2032 Base Year 2024 Forecast Period 2025-2032 Historical Data 2021-2023 Report Scope & Coverage Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook Key Drivers • Rising Industrial Wastewater Discharge Regulations Propel the Demand for Advanced Water Treatment System Installations Globally.
If You Need Any Customization on Water Treatment System Market Report, Inquire Now @ https://www.snsinsider.com/enquiry/7394
Reverse Osmosis Leads Technology, Point-of-Use Dominates Installation, and Residential Sector Spurs Demand
By Technology
In 2024, the reverse osmosis (RO) systems segment emerged as the dominant technology in the Water Treatment System Market, accounting for over 28.00% of the total revenue share. This impressive performance is due mainly to RO's reputation for the removal of a broad range of contaminants, including heavy metals, dissolved salts, and pathogen removal. Their excellent purification efficiency, which can be applied to civil and industrial applications, makes it a preferred option for the system. This distinct property of enhancing water taste and lowering total dissolved solids (TDS) drives the demand owing to water salinity and pollution issues in the region.
By Installation
The point-of-use (POU) segment led the installation category in 2024, generating the highest revenue due to growing consumer awareness regarding water quality and the presence of harmful substances in tap water. Typically, these are installed either under a sink or at selected faucets and supply you with clean water at the point of use instead of putting in place a complete household plumbing system. They are very popular in urban households because of their compact size, simple installation, and low cost. Significant POU (point-of-use) and compact treatment packs boasting due to the rising adoption of POU units in apartments and small homes, are fuelling the growth of POU systems in the Water Treatment System Market.
By Application
The residential application segment accounted for the largest share, approximately 38% of the Water Treatment System Market in 2024. This supremacy is primarily spurred by increasing worries about drinking water quality, particularly in high-population centers and areas where water infrastructure is aging. With consumers becoming more health-conscious, households have begun to utilize various advanced filtration systems like RO units, carbon filters, and UV purifiers to achieve clean and drinkable water. Other factors influencing revenues of the global residential water treatment systems market include a rise in disposable income amongst the consumers and an increasing trend of health-conscious living.
North America Emerges as Fastest-Growing Region with Rising Infrastructure Investments and Smart Solutions
Asia Pacific held the highest revenue share of about 35.28% in 2024. Factors driving this include rapid industrialization, urban growth, and population expansion in countries like China, India, and Southeast Asia. Moreover, rising investments in custom-based water treatment system technologies are fulfilling local demand, ranging from municipal treatment plants to residential purifiers. Innovative, cost-effective solutions are being implemented by governments and private players to solve potable and industrial water issues. Increasing consumer awareness towards clean water, growing from recurring contamination scares, is also playing a key role in propelling the demand for more advanced systems such as reverse osmosis, filtration, and disinfection technologies. With the rapid proliferation of industries and urban consumption, the need for an integrated water treatment network is increasing in parallel.
North America is projected to grow at a high CAGR of nearly 8.69% during 2025–2032. The demand is fueled by regulatory mandates such as the provisions in the Safe Drinking Water Act, increasingly stringent environmental standards, and rising levels of private capital investment in water infrastructure. But U.S. consumers and industries are looking for new systems that can eliminate next-generation contaminants, such as PFAS, microplastics, and drug residuals. Utility companies are seeking digital and IoT-empowered water treatment systems to better monitor systems, cut waste, and enhance performance. At the same time, the use of point-of-use and point-of-entry systems is growing in both residential and commercial sectors due to rising quality concerns, and with many water infrastructure systems becoming old.
Buy Full Research Report on Water Treatment System Market 2025-2032 @ https://www.snsinsider.com/checkout/7394
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Yahoo

24 minutes ago

• Yahoo

Africa Animal Feed Grade Calcium Phosphate - CAS 7757-53-9 Market to Worth Over US$ 372.67 Million By 2033

Africa animal feed grade calcium phosphate - CAS 7757-53-9 market is poised for growth, driven by regulatory advancements, sustainable practices, increasing livestock populations, and expanding feed mill capacities, fostering innovation and regional supply chain improvements. Chicago, June 23, 2025 (GLOBE NEWSWIRE) -- The Africa animal feed grade calcium phosphate - CAS 7757-53-9 market is projected to hit the market valuation of US$ 372.67 million by 2033 from US$ 234.84 million in 2024 at a CAGR of 5.35% during the forecast period 2025–2033. During 2023–2024, ministries of agriculture in Egypt, Kenya, South Africa and Nigeria tightened micronutrient labelling rules for compound feed, directly affecting the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Egypt's Decree 134/2023 raised minimum available phosphorus from 17 g/kg to 18 g/kg and mandated cadmium below 5 mg/kg. The Nigerian National Agency for Food and Drug Administration and Control now demands traceability that links phosphate consignments back to specific mines. These stricter standards discourage low-purity imports and stimulate procurement from Moroccan, Tunisian and Senegalese processors with ISO 22000 certification. Consequently, distributors in Mombasa and Durban are revising protocols and installing X-ray fluorescence scanners at port warehouses. Download Sample Pages: The same regulatory momentum is harmonizing test methods under the African Organization for Standardization, which circulated draft ARS 1783 in February 2024. Stakeholders expect adoption within 18 months, after which inter-country consignments will require only one certificate of analysis. This simplification is already spurring pre-orders, giving the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market clearer forward visibility. Veterinarians advising large poultry firms in Gauteng report a 12-day cut in compliance turnaround thanks to digitized permits, speeding bulk contracts for loads above 3,000 tons. Such developments show how governance, rather than price, now shapes supplier preference within the Africa market. Africa animal feed grade calcium phosphate - CAS 7757-53-9 market Market Forecast (2033) US$ 372.67 million CAGR 5.35 % By Purity Type Medium-Purity Animal Feed Grade Calcium Phosphate (95-98%) (37.13%) By Product Type Mono-Calcium Phosphate (MCP) (39.26%) By Production Method Wet-Process Phosphoric Acid (50.63%) By Form Granule (63.79%) By Application Poultry Feed (31.07%) By Distribution Channel Offline (65.31%) Top Drivers Rising livestock production boosts demand for nutritional additives. Government support for agriculture increases feed additive adoption. Growing poultry sector in Nigeria drives market expansion. Top Trends Shift towards high-purity calcium phosphate for premium feed. Increased focus on sustainable production in South Africa. Customized feed solutions gaining traction across African farms. Top Challenges High import costs limit access for small-scale farmers. Inconsistent supply chains disrupt market in rural Africa. Lack of awareness hinders adoption in underdeveloped regions. Phosphate Rock Supply Chains and Processing Capacities Driving Cost Realities North Africa remains the backbone source of feed-grade phosphates for sub-Saharan formulators, with Morocco's OCP extracting 32 million tons of phosphate rock in 2023 from the Khouribga, Benguerir and Youssoufia complexes. Out of this stream, 1.4 million tons were upgraded into animal-feed monocalcium and dicalcium lines at Jorf Lasfar and Safi, then shipped through bagging terminals with anti-caking additives. Tunisia's Gafsa basin, recovering from strike disruptions, restored output to three million tons, allowing producer Groupe Chimique Tunisien to reopen line 2 of its Sfax feed-grade plant in March 2024. Senegal's ICS added a twin rotary kiln enabling 180,000-ton dicalcium throughput, aimed primarily at Ghanaian and Ivorian feed mills. Despite rising volumes, freight bottlenecks remain the pivotal cost driver. Cape-Sized rates from Jorf Lasfar to Mombasa hit US$ 42 per ton in January 2024 after Red Sea re-routing, then slipped to US$ 29 by May. Producers responded by extending CIF contracts to Dar es Salaam distributors, cushioning formulators and stabilizing the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. A micronizing corridor near Richards Bay now toll-grinds Tunisian granules to 425-micron powder, trimming factory energy bills by eight kWh per ton. As more grinding hubs open, logistics savings should preserve the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market's cost edge over South American alternatives. Livestock Population Shifts Elevating Demand For Bone Strengthening Minerals FAO's 2024 update shows Africa raising 1.28 billion chickens, 350 million goats, 200 million cattle and 35 million dairy cows, a scale that keeps mineral nutrition firmly on procurement agendas. Modern genetics magnify the trend: trials at South Africa's Arcadia center reveal today's Cobb broilers consuming 1.7 grams more available phosphorus per kilogram of live weight than 2019 lines, requiring an extra 0.4 kg of dicalcium phosphate per metric ton of feed. Nigerian formulators in Ogun State corroborate the shift, now employing in-feed optical sensors to meter calcium phosphate precisely and avoid growth dips during hot-weather feeding windows. Urbanization has spurred dairy clusters around Cairo, Addis Ababa and Nairobi, where cows yield 6,500 liters annually on total-mixed rations. A 2023 survey by the Ethiopian Meat and Dairy Industry Institute logged 14 grams of supplemental calcium phosphate per cow per day in these systems. Such evidence shows that the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market increasingly mirrors stocking-density hotspots. Feed plants in Kiambu now draw 900 tons monthly after farms installed automated calf stations in November 2023, while early orders linked to a 60,000-head Brahman feedlot program in northern Côte d'Ivoire are already visible on Dakar export dashboards, reinforcing upside for the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Regional Feed Mill Investments Transforming Localized Formulation and Distribution Patterns Since 2022, fourteen greenfield feed mills have come online across East and West Africa, adding 2.1 million tons of pelleting capacity. Highlights include Biyinzika Pro's 240,000-ton unit in Buikwe, Uganda, and Flour Mills of Ghana's mega-plant at Tema harbour, which unloads 30-ton calcium-phosphate silos directly from pneumatic trucks. These facilities shift procurement inland: before commissioning, Ugandan integrators trucked nine-hundred-kilogram bags of dicalcium from Mombasa; they now book bulk tankers via the Mukuru barge terminal, shaving four days from turnaround. Automation tightens inclusion accuracy, with Tema's loss-in-weight feeders dosing calcium phosphate to 10-gram resolution in line with September 2023 breeder standards. The investment wave directly reshapes the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Because new mills sit close to grain baskets, inbound phosphate moves shorter distances, reducing bag breakage and encouraging a switch to micro-granules over fine powder. Moroccan supplier Phosfeed logged a ten-fold rise in 1.4-millimetre granule orders from Kenya between October 2023 and April 2024, after the Naivasha mill retrofitted its bins with low-angle agitators. Transport firms add that the coarser grade flows smoothly through 20-foot flexi-bags, enabling sunflower-cake backhauls and lifting average truck loads to 46 tons. As more producers replicate the setup, supply chains will tighten further, underpinning reliability in the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Competition Dynamics Between Dicalcium and Monocalcium Phosphate Suppliers Intensify Monocalcium phosphate (MCP) has long dominated layer and aquaculture diets in China and Europe, yet in Africa dicalcium phosphate (DCP) still accounts for roughly four out of five consignments. The technical gap, however, is closing. Field data from the Rwanda Tilapia Research Station published January 2024 show MCP delivering a 30-gram higher final weight in 18-week grow-outs, an advantage valued at US$ 18 per ton of feed. As a result, Ugandan fish-feed maker NaFICO switched three of its five lines to MCP in March, placing a 6,600-ton annual contract with Yunnan Phosphate Haikou's Durban hub. South African integrator Astral also initiated MCP trials across its parent-stock barns in April. This shift is redefining the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. MCP lands in Lagos at US$ 610 per ton, roughly US$ 45 dearer than DCP, yet provides 6.5 grams of available phosphorus in a 30-gram dose against DCP's 5.4. Broiler formulation trials show the premium offset within eight days of grow-out thanks to better feed conversion. Moroccan exporter Europhos has responded with a 'Di-Mono Flex' grade blending MCP and DCP in a three-to-two ratio for stepwise adoption. Cameroun's Somdiaa mill booked 2,400 tons of the blend for Q2 2024, demonstrating how competitive innovation is reshaping the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Price Trend Analysis: Freight, Energy And Currency Variables Determine Margins Feed-grade DCP prices in Africa have swung sharply since mid-2023, driven more by energy and currency moves than raw phosphate. In September 2023 Moroccan DCP landed in Abidjan at US$ 530 per ton when Brent crude sat near US$ 92, inflating sulphuric-acid costs. By February 2024 the same cargo fetched US$ 480 as oil softened and Senegal ended a power-rationing mandate, restoring kiln output. Currency shifts complicate matters: the naira's fall from 762 to 1,300 per US dollar between June 2023 and January 2024 forced Lagos distributors to shorten quotation validity from 90 to 21 days. These swings shape trading strategies inside the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. East African integrators now hedge diesel by buying DCP on a delivered-factory basis that locks freight surcharges for 60 days. Several distributors index invoices to shillings, rand and euros, avoiding single-currency shocks. Forwarders note that every US$ 10 move in bunker fuel lifts the landed price of Moroccan DCP in Mombasa by US$ 2.4 per ton, or 0.6 US cents per kilogram of finished broiler feed. With Suez convoys flowing again, analysts anticipate a stable pricing channel through late 2024, granting the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market its first period of predictable costs since 2021. Request Report Customization: Strategic Opportunities For New Entrants And Existing Players Through 2028 Regulatory convergence, infrastructure upgrades and heavier animal weights are opening the door to fresh suppliers. AgBioTrack projects that by 2026 six new blending or repacking hubs will be required in Nigeria, Kenya and Tanzania to match feed-mill growth. Chinese producer Chongqing Sansheng is scouting a 20,000-ton bagging site in Port Harcourt to cut lead times from ten weeks to three, while Turkey's Toros Tarim inked a February 2024 deal with the Port of Beira for a 40,000-ton terminal that will break-bulk Moroccan MCP for Malawi and Zambia, trimming north-south haulage by 200 kilometers. Such moves position the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market for sharper competition, yet service quality remains decisive. Integrated poultry groups now demand vendor-managed inventory with 21-day visibility, and suppliers offering live dashboards secure repeat orders. Phosfeed's VMI pilot at Rwanda's Uzima Farms eliminated emergency haulage in six months. Technical support is another lever: OCP's mobile lab analyzed 1,800 feed samples across eleven countries in 2023, helping mills refine calcium-to-phosphorus ratios. Sustainability will also count; players documenting cradle-to-farm carbon footprints are likely to gain preferred status when major retailers introduce stricter sourcing charters in 2025, bolstering prospects across the Africa animal feed grade calcium phosphate - CAS 7757-53-9 market. Africa Anima Feed Grade Calcium Phosphate -CAS 7757-53-9 Market Key Players: Phosphea (Groupe Roullier) OCP Group Yara International Hubei Xingfa Chemicals Group Co., LTD Phosagro Nutrien Ltd. Polifar Group Limited The Mosaic Company Ecophos (Prayon Group) Other Prominent Players Key Market Segmentation: By Purity Type High-Purity Animal Feed Grade Calcium Phosphate (≥98%) Medium-Purity Animal Feed Grade Calcium Phosphate (95-98%) Low-Purity Animal Feed Grade Calcium Phosphate (<95%) By Product Type Mono-Calcium Phosphate (MCP) Di-Calcium Phosphate (CP) MCP (Mixed CP/MCP) Tri-Calcium Phosphate (TCP) Others By Production Method Wet-Process Phosphoric Acid Hydrochloric Acid Process Defluorinated Phosphate (Thermal Process) By Form Powder Granules By Application Poultry Feed Cattle Feed Ruminant Feed (Cattle, Sheep) Swine Feed Aquaculture Feed Others By Distribution Channel Online Offline Direct Distributors Retail Feed Stores Others (Importers & Traders) By Country Africa South Africa Namibia Botswana Zimbabwe Mozambique Zambia Rest of Africa Need More Info? Ask Before You Buy: About Astute Analytica Astute Analytica is a global market research and advisory firm providing data-driven insights across industries such as technology, healthcare, chemicals, semiconductors, FMCG, and more. We publish multiple reports daily, equipping businesses with the intelligence they need to navigate market trends, emerging opportunities, competitive landscapes, and technological advancements. With a team of experienced business analysts, economists, and industry experts, we deliver accurate, in-depth, and actionable research tailored to meet the strategic needs of our clients. At Astute Analytica, our clients come first, and we are committed to delivering cost-effective, high-value research solutions that drive success in an evolving marketplace. Contact Us:Astute AnalyticaPhone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)For Sales Enquiries: sales@ Follow us on: LinkedIn | Twitter | YouTube CONTACT: Contact Us: Astute Analytica Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World) For Sales Enquiries: sales@ Website: in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Yahoo

28 minutes ago

• Yahoo

51Talk Online Education Group to Present at the Small Cap Growth Virtual Investor Conference June 26th, 2025

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at SINGAPORE, June 23, 2025 (GLOBE NEWSWIRE) -- 51Talk Online Education Group (NYSE American: COE), based in Singapore, focused on global online education, today announced that David Chung, the Company's investor relations vice president, will present live at the Small Cap Growth Virtual Investor Conference hosted by on June 26th, 2025. DATE: June 26th, 2025TIME: 9:30 a.m. EDTLINK: REGISTER HERE Available for 1x1 meetings: June 26th, 2025 This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at Recent Company Highlights Gross billings for the first quarter of 2025 were US$21.9 million, a 74.6% growth from the first quarter of 2024. Net revenues were US$18.2 million for the first quarter of 2025, a 93.1% increase from US$9.4 million for the first quarter of 2024. The number of active students with attended lesson consumption was approximately 81,100 in the first quarter of 2025, representing a 75.5% increase from approximately 46,200 for the first quarter of 2024. About 51Talk Online Education Group 51Talk Online Education Group (NYSE American: COE) is a global online education platform with core expertise in English education. The Company's mission is to make quality education accessible and affordable. The Company's online and mobile education platforms enable students to take live interactive English lessons, on demand. The Company connects its students with a large pool of highly qualified teachers that it assembled using a shared economy approach, and employs student and teacher feedback and data analytics to deliver a personalized learning experience to its students. About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. CONTACTS:51Talk Online Education GroupDavid ChungInvestor Relations Vice President davidchung@ WangInvestor Relations Managerwangjinling@ Virtual Investor Conferences John M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group (212) 220-2221johnv@ in to access your portfolio

Yahoo

29 minutes ago

• Yahoo

BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers

Head-to-head study comparing BioREtain®- processed Amnion Chorion (BR-AC) allograft to standard of care initiated in Q4 2024 to demonstrate healing superiority Topline results and full data analysis expected in Q4 2025 POMPANO BEACH, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. ('BioStem' or the 'Company') (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced that patient enrollment has been completed in the Company's clinical trial evaluating BioREtain® Amnion Chorion (BR-AC) versus standard of care for patients with non-healing diabetic foot ulcers (DFUs). The BR-AC-DFU-101 study is a multicenter, randomized, controlled trial that was initiated in Q4 2024 at 11 sites across the U.S. to evaluate at least 60 patients with non-healing DFUs. The primary objective is to determine whether DFUs treated with standard care plus BR-AC achieve a higher probability of complete wound closure over a 12-week period when compared to standard care alone. BioStem recently completed enrollment of 71 patients in the study, with topline data expected to be reported during the fourth quarter of 2025. 'We are currently advancing three clinical trials to demonstrate the efficacy and competitive advantage of BioREtain®-processed allografts,' said Jason Matuszewski, CEO and Chairman of the Board of BioStem Technologies. 'I'm pleased that this trial has completed patient enrollment and remains on schedule to report results later this year. We continue to enroll patients in two additional studies targeting venous leg ulcers using BR-AC and diabetic foot ulcers using BR-A. Both trials remain on schedule and reflect our commitment to building a strong body of clinical evidence. We believe the results of these studies will further validate the BioREtain® allograft platform and support expanded physician adoption and commercial expansion.' Trial Primary & Secondary Outcome Objectives:The primary outcome of the study is to determine whether DFUs treated with standard care plus BR-AC results in a higher probability of achieving complete wound closure compared to standard care alone over a 12-week period. Secondary outcome measures include: Comparing treatment group differences in proportions of wounds achieving complete wound closure based on time in days. Comparing treatment group differences in wound area and volume. Assessing total number of applications of BR-AC required to achieve complete wound closure. Clinical Trial Information:For more information about the BR-AC-DFU-101 study, please visit Clinical for a full overview: Title: A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated with Standard Care with or Without BR-AC Link: HERE Diabetic Foot Ulcer Market Statistics:Diabetic foot ulcers (DFUs) are a serious and chronic condition affecting millions of individuals within the diabetic population. According to the American Podiatric Medical Association (APMA), a leading authority on foot and ankle health, approximately 15% of people with diabetes will develop foot ulcers. Alarmingly, 6% of these individuals may require hospitalization due to infections or other complications related to their ulcers. The risks for diabetic patients are substantial, as DFUs are the leading cause of lower extremity amputations in the U.S. Studies indicate that between 14% and 24% of individuals with diabetes who develop foot ulcers will ultimately need an amputation. Recent data analysis from GlobalData Plc., a prominent global data provider, revealed that 2.2 million patients received treatment for DFUs in 2023, with numbers projected to rise in the coming years. The economic burden of these ulcers on healthcare systems is significant, with annual treatment costs estimated between $9 billion and $13 billion in the United States alone. About BioREtain®:BioStem's allografts are processed utilizing the Company's proprietary BioREtain® method, which retains the tissue's native properties while maintaining the structure and matrix found in fresh perinatal tissue. The patented six-step BioREtain® process is gentle, minimally invasive, and preserves the natural integrity of the amniotic tissue components critical to wound treatment. For a full overview of BioREtain®, please visit: HERE. Join BioStem's Distribution List & Social Media:To stay informed on the latest developments, sign-up for the Company's email distribution list HERE, and follow us on X and LinkedIn. About BioStem Technologies, Inc. (OTC: BSEM):BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for advanced wound care. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioREtain® processing method. BioREtain® has been developed by applying the latest research in advanced wound care, focused on maintaining growth factors and preserving tissue structure. BioStem's quality management systems and standard operating procedures are accredited by the American Association of Tissue Banks ('AATB') and adhere to Good Tissue Practices (cGTP and Good Manufacturing Processes ('cGMP'). Our portfolio of quality brands includes AmnioWrap2™, VENDAJE®, VENDAJE AC®, VENDAJE OPTIC®, American Amnion and American Amnion AC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida. For more information visit and follow us on X and LinkedIn. Contact BioStem Technologies, Inc.:Phone: 954-380-8342Website: info@ @BSEM_TechFacebook: BioStemTechnologies Investor Relations:Adam HoldsworthE-Mail: adam@ 917-497-9287 Note Regarding Forward-Looking Statements: Except for statements of historical fact, this press release also contains forward-looking statements. These forward-looking statements relate to expectations or forecasts of future events, including with respect to the operations of the Company, strategies, prospects and other aspects of the business of the Company. Forward-looking statements may be identified using words such as 'forecast,' 'intend,' 'seek,' 'target,' 'anticipate,' 'believe,' 'expect,' 'estimate', 'plan,' 'outlook,' and 'project' and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements in this press release include, among other things, statements regarding the Company's: ability to clear all current SEC comments; expectations regarding filing an amended Form 10, including the timeframe therefor and the content therein; and expectations regarding the Company's plan and ability to satisfy Nasdaq listing requirements. Forward-looking statements are based on current expectations that are subject to known and unknown risks and uncertainties, which could cause actual results or outcomes to differ materially from the expectations expressed or implied by such forward-looking statements. These factors include, but are not limited to: the risk that the Company may be unable to list its stock on Nasdaq or maintain compliance with Nasdaq's continued listing standards; the impact of any changes to the accounting treatment of the Company's revenue and expenses; the risk of receiving additional comments from the SEC; the competition that the Company faces, which could adversely affect its business, results of operations and financial condition; the risk of rapid technological change, which could cause the Company's products to become obsolete or cause the Company to become unable to effectively compete; the risk that the Company is unable to successfully market its products to the end users of such products; the risk that the Company may be unable to raise funds to expand its business; changes in applicable laws or regulations; and the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. The Company undertakes no commitment to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data